Systemic Chemotherapy, Lenvatinib Plus Sintilimab for ICC With Distant Metastasis

NCT04769908 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

ICC

Interventions

DRUG: Systemic Chemotherapy
DRUG: Lenvatinib
DRUG: Sintilimab

Sponsor

Sun Yat-sen University